In our translational research projects, we are primarily using patient samples instead of animal models and cell lines, as we hope that in this way the results can be more readily incorporated into clinical patient care. Our main research interests are tumor immunology, autoimmunity and personalized medicine for various leukemia types.

We have several academic and company-sponsored clinical trials ongoing (both phase I and phase II) studying the effects of tyrosine kinase inhibitors (imatinib, dasatinib, nilotinib, bosutinib) in combination with other drugs. Our laboratory and clinical study center currently employs 3 study nurses (2 full-time, 1 part-time), a scientific secretary (part-time) and 4 clinical investigators (1 full-time, 3 part-time). More information about the ongoing studies in CML can be found in the web page.